[EN] THERAPEUTIC COMPOUNDS AND USES THEREOF<br/>[FR] COMPOSÉS THÉRAPEUTIQUES ET LEURS UTILISATIONS
申请人:GENENTECH INC
公开号:WO2016055028A1
公开(公告)日:2016-04-14
The present invention relates to compounds of formula (I): and to salts thereof, wherein A has any of the values defined in the specification, and compositions and uses thereof. The compounds are useful as inhibitors of CBP and/or EP300. Also included are pharmaceutical compositions comprising a compound of formula (I) or a pharmaceutically acceptable salt thereof, and methods of using such compounds and salts in the treatment of various CBP and/or EP300-mediated disorders.
The selective oxidation of C2-alkyl-substituted indoles to 3-oxindole and the selective C–H oxygenation or amination of C2,C3-dialkyl-substituted indoles at C2 are reported under mild conditions. The position of the alkyl substitution on the indole directs the reaction to different pathways under similar conditions.
One-pot, three-component Fischer indolisation–<i>N</i>-alkylation for rapid synthesis of 1,2,3-trisubstituted indoles
作者:Christopher A. Hughes-Whiffing、Alexis Perry
DOI:10.1039/d0ob02185g
日期:——
A one-pot, three-component protocol for the synthesis of 1,2,3-trisubstituted indoles has been developed, based upon a Fischer indolisation–indole N-alkylation sequence. This procedure is very rapid (total reaction time under 30 minutes), operationally straightforward, generally high yielding and draws upon readily available building blocks (aryl hydrazines, ketones, alkyl halides) to generate densely
Investigation of the reaction of<i>N</i>-substituted indolylborates: Palladium catalyzed cross-coupling reactions and intramolecular alkyl migration reactions
作者:Minoru Ishikura、Isao Agata、Nobuya Katagiri
DOI:10.1002/jhet.5570360408
日期:1999.7
The palladium catalyzed cross-couplingreaction of indolylborates with various N-protecting groups was investigated, where N-Methyl, N-methoxy, and N-tert-butoxycarbonyl groups were found to be useful. However, triethyl(1-methoxymethylindol-2-yl)borate could not be used for this reaction. It was also found that the alkyl migration reaction of trialkyl(1-methoxymethylindol-2-yl)borate produced 2-alkyl-1-methyl-indole
The invention provides a method of activating PPAR γ and a method of treating or preventing a disease associated with PPAR γ by administering a tricyclic compound having a PPAR γ agonist activity, which is represented by the formula (I) wherein Z represents a single bond or the like, Y represents a hydrogen atom, lower alkyl optionally having substituent(s) or the like, X represents a hydrogen atom or the like, A represents aryl or the like, B and C are the same or different and each represents an aromatic carbocycle or the like, R
4
-R
9
are the same or different and each represents hydrogen or the like, V represents a single bond or the like, R
10
and R
11
are the same or different and each represents hydrogen or the like, or a pharmaceutically acceptable salt thereof or the like: